19 September: Appendix 4G & Corporate Governance Statement
190919_Appendix 4G & Corporate Governance Statement
19 September: Annual_Report
190919_Annual_Report
17 September: Appendix 3B – Exercise of Options
190917_Appendix 3B Exercise of Options
Agreement with U-Vet for Phase II Trial in Pet Dogs with Cancer Finalised
190910_UniMelb_U-Vet Agreement
Investor Roadshow Presentation September 2019
190909_Investor Roadshow Presentation September 2019
Phase II Dog Cancer Trial Commences
190909_Phase II Dog Cancer Trial Commences
30 August 2019 Top 20 Shareholders
Top Holders August 2019
Appendix 4E Preliminary Final Report
190830_Preliminary Final Report
Appendix 3B and s708 Notice
190828_Appendix 3B & s708 notice
Arrival of GMP Tablets for Phase II Dog Trials
190826_GMP Tablets Arrive_447v3rv314vgd9